PAG1 and glioblastoma: Additionally, knockout of PAG1 or ZNF830 in GSCs delayed the onset of neurological signs in orthotopic glioblastoma xenografts compared to GSCs treated with a non-targeting sgRNA (Fig. 8n–q).